Siemens Healthineers Opens AI Healthcare Innovation Center in Madrid

Siemens Healthineers has officially opened its first Center for the Adoption of Artificial Intelligence (AI) in Healthcare in Southern Europe in Madrid. This new space aims to accelerate the digital transformation of healthcare and support hospitals, healthcare professionals, and institutions in the large-scale implementation of AI in clinical practice, improving diagnostic efficiency and therapeutic precision.

The center opened by Siemens Healthineers will have up to 120 specialized professionals, who will work in collaboration with more than 300 hospitals and health centers in Spain, Portugal, Italy, and Greece, regions advanced in healthcare technology but with room for improvement in the clinical adoption of AI-based solutions.

“Innovation without adoption is just theory. The real challenge for the sector isn’t creating more disruptive technologies, but rather ensuring they are integrated into clinical practice , which is where the greatest lack of knowledge exists. That’s why we created this center, whose objective is simple: to offer training and strategic consulting to professionals, as well as to develop co-creation and technological implementation projects, in addition to spaces for innovation and dissemination. All of this, with the aim of ensuring that more and more patients can benefit from the real impact that AI can have on their lives,” says David Labajo, Director of Innovation at Siemens Healthineers for Southern Europe.

Siemens Healthineers plans to have up to 120 specialized professionals to support the digital transformation of healthcare.

Siemens Healthineers center: A model of clinical and technological collaboration

To ensure an approach aligned with clinical needs in areas such as oncology and neurology, the center has an Advisory Board with representatives from different countries and AI specialists, who work alongside the Scientific Collaborations team, led by scientist Davide Piccini.

In addition, it is part of an ecosystem of strategic partners that includes accelerators and startups such as MeThinks (stroke), SincroLab (cognitive impairment and Alzheimer’s), and IQM (quantum computing). It also collaborates with Circular LAB, a platform that digitizes and centralizes biomarker data to facilitate evidence-based diagnoses.

The center will offer training, strategic consulting, and technological co-creation projects with hospitals and healthcare institutions.

The opening of this hub is part of the global SHIFT Open Innovation program, which strengthens Siemens Healthineers’ international network of Innovation Centers in key markets such as Germany, China, and India. ” This new center is a key step toward democratizing innovation across markets, facilitating regional knowledge sharing and the development of solutions that improve clinical care. By combining our technological expertise with open collaboration, we are empowering innovators to transform healthcare practice and generate a tangible, positive impact on patients around the world,” emphasizes Amira Romani , Senior Vice President of Global Innovation and Technology at Siemens Healthineers.

Upcoming innovation meetings

In the short term, the Siemens Healthineers center will promote key activities in the region, such as MedTech Meets AI, held on October 2 and 3 in Barcelona, ​​bringing together healthcare and technology leaders to discuss the future of AI applied to health. It will also participate in the Humanitas Radiology Hackathon in Milan, focused on developing innovative algorithms and clinical applications.

__

(Featured image by Alex Azabache via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in iSanidad. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.